Robert Burrows | VP, IR |
Robert Kramer | CEO, President & Executive Director |
Richard Lindahl | EVP, CFO & Treasurer |
Adam Havey | EVP, Business Operations |
Brandon Folkes | Cantor Fitzgerald & Co. |
Dana Flanders | Guggenheim Securities |
Jessica Fye | JPMorgan Chase & Co. |
Keay Nakae | Chardan Capital Markets |
Lisa Springer | Singular Research |
Thank you for standing by, and welcome to the Emergent BioSolutions First Quarter 2021 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to Bob Burrows. Please go ahead.
Thank you, Cindy.